Clin Mol Hepatol.
2017 Jun;23(2):125-127. 10.3350/cmh.2017.0106.
Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign?
- Affiliations
-
- 1Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea. nyheo@hanmail.net
- KMID: 2413115
- DOI: http://doi.org/10.3350/cmh.2017.0106
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
- The mechanism and treatment of anti-viral resistant hepatitis B virus
- Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients
- Seroreversion and Acute Decompensation in Chronic Hepatitis B after Discontinuation of Oral Nucleotide Analog in the Patients Achieving HBsAg Loss
- Unmet need in chronic hepatitis B management
